FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism.

FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism.

Item
http://www.wikidata.org/entity/Q34688048
Novel endogenous angiogenesis inhibitors and their therapeutic potentialDecellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interactionGenome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway.FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis.FKBPL: a marker of good prognosis in breast cancer.Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer ProgramRALA-mediated delivery of FKBPL nucleic acid therapeuticsThe emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPL.Perspectives of CD44 targeting therapies.Biological relevance of Hsp90-binding immunophilins in cancer development and treatment.HSP90AB1: Helping the good and the bad.Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen.The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer.Low-frequency nonsynonymous variants in FKBPL and ARPC1B genes are associated with breast cancer risk in Chinese women.
P2860

FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism.

Item
http://www.wikidata.org/entity/Q34688048
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
FKBPL and peptide derivatives: ...... by a CD44-dependent mechanism.
@ast
FKBPL and peptide derivatives: ...... by a CD44-dependent mechanism.
@en
FKBPL and peptide derivatives: ...... by a CD44-dependent mechanism.
@nl
type
label
FKBPL and peptide derivatives: ...... by a CD44-dependent mechanism.
@ast
FKBPL and peptide derivatives: ...... by a CD44-dependent mechanism.
@en
FKBPL and peptide derivatives: ...... by a CD44-dependent mechanism.
@nl
prefLabel
FKBPL and peptide derivatives: ...... by a CD44-dependent mechanism.
@ast
FKBPL and peptide derivatives: ...... by a CD44-dependent mechanism.
@en
FKBPL and peptide derivatives: ...... by a CD44-dependent mechanism.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
FKBPL and peptide derivatives: ...... by a CD44-dependent mechanism
@en
P2093
P2860
P304
P31
P356
10.1158/1078-0432.CCR-10-2241
P407
P433
P478
P50
P577
P698
P932